ArticleInvestigative ophthalmology & visual science2024
Evaluating the Impact of Retinal Vessel Segmentation Metrics on Retest Reliability in a Clinical Setting: A Comparative Analysis Using AutoMorph.
Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Automated Retinal Vascular Analysis Reveals Response to Acetazolamide in Idiopathic Intracranial Hypertension.Translational vision science & technology · 2025Trial
- Predictive Modeling of Coronary Artery Disease Using Color Fundus Photography-Based Features of Retinal Vasculature.Ophthalmology and therapy · 2026Article
- Retinalysis-Vascx: An Explainable Software Toolbox for the Extraction of Retinal Vascular Biomarkers From Color Fundus Images.Translational vision science & technology · 2026Article
- The retina-body axis: proteomic mechanisms linking oculomics and clinical traits in a female aging cohort.npj aging · 2026Article
- Retinal vessel segmentation using multi scale feature attention with MobileNetV2 encoder.Scientific reports · 2025Article
- Retinal Microvascular Biomarker Assessment With Automated Algorithm and Semiautomated Software in the Montrachet Dataset.Translational vision science & technology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Purpose: Current research on artificial intelligence-based fundus photography biomarkers has demonstrated inconsistent results. Consequently, we aimed to evaluate and predict the test-retest reliability of retinal parameters extracted from fundus photography. Methods: Two groups of patients were recruited for the study: an intervisit group (n = 28) to assess retest reliability over a period of 1 to 14 days and an intravisit group (n = 44) to evaluate retest reliability within a single session. Using AutoMorph, we generated test and retest vessel segmentation maps; measured segmentation map agreement via accuracy, sensitivity, F1 score and Jaccard index; and calculated 76 metrics from each fundus image. The retest reliability of each metric was analyzed in terms of the Spearman correlation coefficient, intraclass correlation coefficient (ICC), and relative percentage change. A linear model with the input variables contrast-to-noise-ratio and fractal dimension, chosen by a P-value-based backward selection process, was developed to predict the median percentage difference on retest per image based on image-quality metrics. This model was trained on the intravisit dataset and validated using the intervisit dataset. Results: In the intervisit group, retest reliability varied between Spearman correlation coefficients of 0.34 and 0.99, ICC values of 0.31 to 0.99, and mean absolute percentage differences of 0.96% to 223.67%. Similarly, in the intravisit group, the retest reliability ranged from Spearman correlation coefficients of 0.55 and 0.96, ICC values of 0.40 to 0.97, and mean percentage differences of 0.49% to 371.23%. Segmentation map accuracy between test and retest never dropped below 97%; the mean F1 scores were 0.85 for the intravisit dataset and 0.82 for the intervisit dataset. The best retest was achieved with disc-width regarding the Spearman correlation coefficient in both datasets. In terms of the Spearman correlation coefficient, the worst retests of the intervisit and intravisit groups were tortuosity density and artery tortuosity density, respectively. The intravisit group exhibited better retest reliability than the intervisit group (P < 0.001). Our linear model, with the two independent variables contrast-to-noise ratio and fractal dimension predicted the median retest reliability per image on its validation dataset, the intervisit group, with an R2 of 0.53 (P < 0.001). Conclusions: Our findings highlight a considerable volatility in the reliability of some retinal biomarkers. Improving retest could allow disease progression modeling in smaller datasets or an individualized treatment approach. Image quality is moderately predictive of retest reliability, and further work is warranted to understand the reasons behind our observations better and thus ensure consistent retest results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.